Published 11/07/2009 by Pharmacy Choice
Hard to Treat Diseases Inc. HTDS Targets an EU Based Stem Cell Research Company for a Merger
- (NewsRx.com) Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, announces that it is targeting an EU based company, and has initiated talks that may involve a merger (see also Hard to Treat Diseases)..
Share this
There are no more reports on this story yet.